COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study (DEEP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01246466
Recruitment Status : Completed
First Posted : November 23, 2010
Last Update Posted : February 29, 2016
Information provided by (Responsible Party):
AtriCure, Inc.

Brief Summary:
The purpose of this clinical investigation is to evaluate how safe a less invasive cardiac surgery is using the AtriCure Bipolar System combined with a catheter ablation procedure in treating AF, and how effective this combined procedure is using the AtriCure System in treating AF. The AtriCure Bipolar System will be used to perform the less invasive cardiac surgery and a standard electrophysiology catheter, currently available, will be used to perform the catheter ablation procedure. This surgical procedure is considered less invasive because it is done through tiny surgical punctures on the sides of the chest near the ribs instead of one large surgical incision of the breast bone to completely open the chest and access the heart, and it also avoids the need for the heart-lung bypass machine.

Condition or disease Intervention/treatment Phase
Persistent Atrial Fibrillation or Longstanding Persistent Atrial Fibrillation Device: Hybrid ablation procedure Phase 1 Phase 2

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 24 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Feasibility Trial of a Hybrid Approach for Treatment of Patients With Persistent or Longstanding Persistent Atrial Fibrillation With Radiofrequency Ablation
Study Start Date : November 2010
Actual Primary Completion Date : December 2012
Actual Study Completion Date : November 2013

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: AtriCure Bipolar System combined with a catheter ablation
procedure using the AtriCure Bipolar System plus a catheter ablation
Device: Hybrid ablation procedure
AtriCure Bipolar System plus a catheter ablation

Primary Outcome Measures :
  1. composite of pre-specified safety endpoints occurring in the first 30 days post-index procedure or hospital discharge, whichever is longer. [ Time Frame: Within the first 30 days post-index procedure or hospital discharge ]
  2. Absence of atrial fibrillation [ Time Frame: 12 month follow-up ]
    Absence of atrial fibrillation (AF) at twelve month follow-up based on an auto trigger event monitor, while off all Class I and III antiarrhythmic therapy.

Secondary Outcome Measures :
  1. Overall Serious Device or Procedure Related Adverse Event Rate [ Time Frame: 12 month follow-up ]
  2. Acute Procedure Success [ Time Frame: Upon completion of the index procedure ]
  3. Absence of atrial fibrillation [ Time Frame: 12 month ]
    Absence of atrial fibrillation after the 3 month blanking period through twelve month follow-up based on auto trigger event monitor.

  4. Incidence of Reintervention [ Time Frame: 12 months ]
  5. Incidence of DC cardioversion [ Time Frame: 12 months ]
  6. Improvement in AF [ Time Frame: 12 months ]
    Improvement in AF Symptom Checklist Frequency and Severity Scores.

  7. Duration of procedure [ Time Frame: index procedure ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Age > 18 years
  2. Patients with symptomatic (e.g. palpitations, shortness of breath, fatigue) persistent or longstanding persistent AF Persistent
  3. Patient is willing and able to provide written informed consent.
  4. Patient has a life expectancy of at least 2 years.
  5. Patient is willing and able to attend the scheduled follow-up visits.

Exclusion Criteria:

  1. Prior Cardiothoracic Surgery.
  2. Patient has NYHA Class IV heart failure.
  3. Evidence of underlying structural heart disease requiring surgical treatment.
  4. Ejection fraction < 30%
  5. Measured left atrial diameter > 6.0 cm
  6. Renal Failure
  7. Stroke within previous 6 months.
  8. Known carotid artery stenosis greater than 80%.
  9. Evidence of significant active infection or endocarditis.
  10. Pregnant woman or women desiring to become pregnant in the next 24 months.
  11. Presence of thrombus in the left atrium determined by echocardiography.
  12. History of blood dyscrasia.
  13. Contraindication to anticoagulation, based on Investigator's opinion.
  14. Mural thrombus or tumor.
  15. Moderate to Severe COPD

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01246466

Layout table for location information
United States, California
Stanford University Medical Center
Stanford, California, United States, 94305
United States, Tennessee
Vanderbilt Heart Institute
Nashville, Tennessee, United States, 37232
United States, Texas
Baylor Health
Plano, Texas, United States, 75093
United States, Virginia
Charlottesville, Virginia, United States, 22908
Sentara Norfolk
Norfolk, Virginia, United States, 23507
Sponsors and Collaborators
AtriCure, Inc.
Layout table for additonal information
Responsible Party: AtriCure, Inc. Identifier: NCT01246466    
Other Study ID Numbers: CP2009-1
First Posted: November 23, 2010    Key Record Dates
Last Update Posted: February 29, 2016
Last Verified: January 2016
Keywords provided by AtriCure, Inc.:
Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation, Ablation, catheter ablation
Additional relevant MeSH terms:
Layout table for MeSH terms
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes